These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7308265)

  • 41. The facilitation of tumour growth in the lung by cyclophosphamide in artificial and spontaneous metastases models.
    de Ruiter J; Cramer SJ; Smink T; van Putten LM
    Eur J Cancer (1965); 1979 Sep; 15(9):1139-49. PubMed ID: 527634
    [No Abstract]   [Full Text] [Related]  

  • 42. Lack of vincristine--cyclophosphamide potentiation in different experimental tumour lines.
    Mulder JH; Lelieveld P; van Putten LM
    Eur J Cancer (1965); 1979 Apr; 15(4):499-507. PubMed ID: 436910
    [No Abstract]   [Full Text] [Related]  

  • 43. Possible benefits of hyperthermia to chemotherapy.
    Kowal CD; Bertino JR
    Cancer Res; 1979 Jun; 39(6 Pt 2):2285-9. PubMed ID: 376118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined radiotherapy--chemotherapy of Lewis lung carcinoma.
    Steel GG; Hill RP; Peckham MJ
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):49-52. PubMed ID: 632147
    [No Abstract]   [Full Text] [Related]  

  • 45. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
    Twentyman PR; Bleehen NM
    Br J Cancer; 1976 Mar; 33(3):320-8. PubMed ID: 57788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of combining the radiosensitizer misonidazole with cyclophosphamide in treating the murine Lewis lung tumor.
    Pedersen JE; Barron G; Meeker BE
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):651-3. PubMed ID: 7107392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma].
    Stoichkov I; Milushev A; Todorov D
    Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy, BCG, and serum from tumor-bearing mice: comparative effects on growth and spread of mouse Lewis lung cancer.
    Greager JA; Culberson G; Manning B; Das Cupta TK
    Arch Surg; 1975 Aug; 110(8):901-2. PubMed ID: 1156156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of ultrasonic hyperthermia with two alkylating agents in a murine bladder tumor.
    Longo FW; Tomashefsky P; Rivin BD; Tannenbaum M
    Cancer Res; 1983 Jul; 43(7):3231-5. PubMed ID: 6406056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
    Horsman MR; Chaplin DJ
    Br J Cancer; 1994 Apr; 69(4):648-54. PubMed ID: 8142253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic response of human lung tumour xenografts to cyclophosphamide.
    Mattern J; Jaeger S; Wayss K; Volm M
    Anticancer Res; 1982; 2(6):355-8. PubMed ID: 7168553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperthermic potentiation of doxorubicin and 4'-epi-doxorubicin in a transplantable neurogenic rat tumor (BT4A) in BD IX rats.
    Dahl O
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):203-7. PubMed ID: 6572622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases.
    Marmor JB; Kozak D; Hahn GM
    Cancer Treat Rep; 1979 Aug; 63(8):1279-90. PubMed ID: 89906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of the inhibitory effect of levan on experimental tumors.
    Leibovici J; Stark Y; Eldar T; Brudner G; Wolman M
    Recent Results Cancer Res; 1980; 75():173-9. PubMed ID: 7232830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Schedule-dependent cytotoxicity of 5-fluorouracil and cyclophosphamide in experimental cancer chemotherapy.
    Mulder JH; Smink T; Ossewaarde T; van Putten LM
    Eur J Cancer (1965); 1980 May; 16(5):699-705. PubMed ID: 6930341
    [No Abstract]   [Full Text] [Related]  

  • 57. [Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability].
    Frankfurt OS
    Vopr Onkol; 1975; 21(10):63-7. PubMed ID: 1189353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experimental study on hyperthermia plus radiation].
    Wang SB
    Zhonghua Zhong Liu Za Zhi; 1982 Aug; 4(3):171-3. PubMed ID: 7173021
    [No Abstract]   [Full Text] [Related]  

  • 59. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

  • 60. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
    Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
    Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.